22:13:47 EDT Thu 02 May 2024
Enter Symbol
or Name
USA
CA



Ndatalyze Corp
Symbol NDAT
Shares Issued 41,027,425
Close 2023-12-21 C$ 0.13
Market Cap C$ 5,333,565
Recent Sedar Documents

Ndatalyze signs clinical study deal with Stevens

2023-12-21 16:36 ET - News Release

Dr. Keith Courtney reports

NDATALYZE CORP. ("NDAT" OR THE "CORPORATION") (CSE:NDAT) (OTC:NDATF) SIGNS A FORMAL CLINICAL STUDY AGREEMENT WITH DR. DALE STEVENS, PH.D., DEPARTMENT OF PSYCHOLOGY, FACULTY OF HEALTH, YORK UNIVERSITY.

Pursuant to terms and conditions of the letter of intent dated Nov. 10, 2023, which LOI was extended on Dec. 11, 2023, Ndatalyze Corp. and Dr. Dale Stevens have today signed a formal clinical study agreement. This agreement remains subject to York University's ethics review but the parties do not expect any issues in this regard.

About YMI

YMI uses evidence-based, objective data from whole life experiences to predict individual mental states over time and applies this knowledge toward a fuller understanding of how mental health develops and to improve mental well-being. YMI combines machine learning with a proprietary reference database that contains greater than 1,200 person's genetic expressions, childhood environment, habits, phobias, lived experiences and lifestyle to generate a personalized graphic report predicting an individual's predisposition toward a variety of common mental conditions, both current and forward in time.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.